What is NDC 33342-091?

33342-091 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 4.5 mg/1 capsule, listed with the FDA by Macleods Pharmaceuticals Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine Tartrate?

36 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine Tartrate NDC 33342-091

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-091Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0091Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-091-06	3334200910633342009106	3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-06) / 10 CAPSULE in 1 BLISTER PACKMarketed from Sep 2, 2014
33342-091-09	3334200910933342009109	60 CAPSULE in 1 BOTTLE (33342-091-09)Marketed from Sep 2, 2014
33342-091-12	3334200911233342009112	10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-12) / 10 CAPSULE in 1 BLISTER PACKMarketed from Sep 2, 2014
33342-091-15	3334200911533342009115	500 CAPSULE in 1 BOTTLE (33342-091-15)Marketed from Sep 2, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine Tartrate
Generic name (nonproprietary): rivastigmine tartrate
Active ingredients: Rivastigmine tartrate — 4.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Macleods Pharmaceuticals LimitedNDC labeler code 33342
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203148
Marketing start: Sep 2, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 33342-091_3ac90f1e-d2a5-4645-972b-0d627e4cc860SPL ID 3ac90f1e-d2a5-4645-972b-0d627e4cc860SPL set ID 4364f6ef-a8da-4805-be0d-aabbe8ca2d21RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0333342089090, 0333342091093, 0333342090096
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342009106 followed by a unit qualifier and the quantity

Package 33342-0091-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 24, 2022.

Indications (excerpt from the label)

Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: • Mild-to-moderate dementia of the Alzheimers type (AD) ( 1.1 ) • Mild-to-moderate dementia associated with Parkinsons disease (PD) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson's Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 33342-091

What is NDC 33342-091?: 33342-091 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 4.5 mg/1 capsule, listed with the FDA by Macleods Pharmaceuticals Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine Tartrate.
What is the active ingredient?: Rivastigmine tartrate.
Who is the labeler?: Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine Tartrate?: 36 other product NDCs are listed under this name. See all Rivastigmine Tartrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine Tartrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	American Health Packaging	60687-777	60687-0777-01
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063	62332-0063-1062332-0063-3062332-0063-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064	62332-0064-1062332-0064-3062332-0064-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065	62332-0065-1062332-0065-3062332-0065-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-066	62332-0066-1062332-0066-3062332-0066-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-011	72241-0011-0372241-0011-10
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-012	72241-0012-0372241-0012-10
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-013	72241-0013-0372241-0013-10
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-014	72241-0014-0372241-0014-10
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-900	62135-0900-60

All 37 Rivastigmine Tartrate NDCs

Other NDCs under ANDA 203148

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203148
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-089
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-090
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-092